Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)

被引：0
|
作者：
Ghosh, Arnab [1 ]
Nagel, Katherine [1 ]
Hosszu, Kinga [1 ]
Datta, Ambika [1 ]
Thompson, Christina [1 ]
Levia, Khayla [1 ]
Kamrowski, Alyssa [1 ]
McAvoy, Devin [1 ]
Chung, David [2 ]
Landau, Heather [2 ]
Scordo, Michael [1 ]
Giralt, Sergio [1 ]
Shah, Gunjan [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant & Cellular Therapy, New York, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-260
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [1] CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma
    Smith, Eric
    Devlin, Sean M.
    Kosuri, Satyajit
    Orlando, Evelyn
    Landau, Heather
    Lesokhin, Alex M.
    Chung, David J.
    Hassoun, Hani
    Lendvai, Nikoletta
    Landgren, Ola
    Giralt, Sergio
    Chari, Ajai
    Jagannath, Sundar
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (02) : 258 - 267
  • [2] Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Malard, F.
    Shah, G. L.
    Seier, K.
    Cho, C.
    Devlin, S. M.
    Maloy, M.
    Borrill, T.
    Palazzo, M.
    van den Brink, M.
    Perales, M-A
    BONE MARROW TRANSPLANTATION, 2017, 52 : S29 - S29
  • [3] Impact of Busulfan Exposure on Transplant Outcomes for Patients with Relapsed Multiple Myeloma Undergoing CD34-Selected Allogeneic Hematopoietic Stem Cell Transplant
    Lin, Andrew
    Drill, Esther
    Proli, Anthony J.
    Beyer, Kristen
    Bhatt, Valkal
    Devlin, Sean M.
    Koehne, Guenther
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S288 - S289
  • [4] Outcome following CD34 selected allogeneic stem cell transplantation for patients with multiple myeloma
    Guillaume, H
    Moreau, P
    Delaunay, J
    Vigouroux, S
    Chevallier, P
    Mahé, B
    Le Gouill, S
    Dubruille, V
    Morineau, N
    Gastine, T
    Bercegay, S
    Saiag, S
    Saulquin, B
    Harousseau, JL
    Milpied, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S141 - S142
  • [5] Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation
    Essmann, S.
    von Pein, U. -M.
    Klyuchnikov, E.
    Janson, D.
    Bonmann, S.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 190 - 190
  • [6] CD34-selected stem cell boost for poor graft function after allogeneic stem cell transplantation for myelofibrosis
    Klyuchnikov, E.
    Lioznov, M.
    Bacher, U.
    Zander, A. R.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S158 - S158
  • [7] Toxicities in older adult patients undergoing CD34+selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Shah, G. L.
    Scordo, M.
    Kosuri, S.
    Herrera, D. Adrianzen
    Maloy, M.
    Nieves, J. L.
    Devlin, S.
    Avecilla, S. T.
    Meagher, R.
    Shaffer, B.
    Perales, M. -A.
    Gyurkocza, B.
    Castro-Malaspina, H.
    Giralt, S. A.
    Tamari, R.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S226 - S227
  • [8] Chimeric Antigen Receptor-T (CAR-T) Cell Therapy Targeting BCMA in Patients with Prior Allogeneic Transplantation (allo-HCT) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
    Hammons, Lindsay
    Haider, Shabi
    Pasquini, Marcelo C.
    Chhabra, Saurabh
    Radhakrishnan, Sabarinath
    Zamora, Anthony E.
    Mohan, Meera
    Dong, Jing
    Janz, Siegfried
    D'Souza, Anita
    Hari, Parameswaran
    Dhakal, Binod
    BLOOD, 2022, 140 : 7215 - 7216
  • [9] Bortezomib and lenalidomide for multiple myeloma patients relapsed after allogeneic stem cell transplantation
    Corradini, P.
    Montefusco, V.
    Bruno, B.
    Merla, E.
    Sorasio, R.
    Olivieri, A.
    Falcone, A.
    Giaccone, L.
    Farina, L.
    Spina, F.
    Dodero, A.
    Milani, R.
    Carella, A. M.
    Cascavilla, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S148 - S148
  • [10] Durable Remission and Survival in Relapsed/Refractory Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation
    Cornelison, A. Megan
    Saliba, Rima M.
    Ahmed, Sairah
    Nieto, Yago
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Patel, Krina
    Hosing, Chitra
    Popat, Uday R.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2016, 128 (22)
12345